1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid
GLP-1 drugs are all the rage on Wall Street today, with demand for these weight loss products expected to be strong for years to come. That’s helped to supercharge Eli Lilly‘s (LLY +0.70%) growth and its stock price. However, you might be better off with this higher-yielding drug peer,
» Read more about: 1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid »